CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR HIV-1 GP160 ANTIGEN AND SYNTHETIC P18III(B) PEPTIDE IN AN HLA-A11-IMMUNIZED INDIVIDUAL

Cytotoxic T cell determinants should be an important component of an a nti-human immunodeficiency virus (HIV) vaccine. The epitopes of protei ns can be defined with short synthetic peptides for class I-restricted CTLs. An immunodominant CTL epitope from the HIV-1 IIIB envelope prot ein gp160 comprising 15 amino acids (residues 315-329: RIQRGPGRAFVTIGK ) (P18III(B)) has been identified that is recognized by class I MHC mo lecule H-2(d)-restricted murine CD8(+) CTLs. We have investigated the epitope specificity of anti-HIV-1 CTLs in immunized individuals and we found that the CTL response was restricted by more than one class I M HC molecule, including HLA-A2 and HLA-A3. In the present work, we also show that the response against P18III(B) peptide is restricted by the HLA-A11 molecule in an individual immunized by vaccinia virus express ing gp160 protein. This peptide could thus be recognized in associatio n with different HLA class I allotypes. This work has implications for vaccine strategies, using the P18 peptide.